Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
130 Million
(Quarterly Results - Mar 2026)
Net Profit:
27 Million
Pharmaceuticals & Biotechnology
SAR 2,081 Million (Micro Cap)
20.00
NA
0.00%
0.15
-999,999.00%
4.98






